GlassScriptPhysician profile
David H Macdonald
NPI 1528285210
$2,775.28
in general payments reported to CMS, 2019-2025
10 companies · $2,399 in 2025
The $2,399 reported for 2025 was more than what 85% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $150 · 2021: $25.41 · 2023: $127 · 2024: $74.16 · 2025: $2,399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,899 · Food and Beverage: $701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,898.52 |
| Food and Beverage | $701.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cgg Medical INC | $1,789.65 | 2023-2025 | |
| Arthrex, INC. | $712.40 | 2025 | |
| Vericel Corporation | $122.23 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $39.24 | 2025 | |
| Horizon Therapeutics Plc | $34.12 | 2023 | Krystexxa |
| Octapharma USA, INC. | $24.59 | 2025 | Panzyga |
| Allergan, INC. | $14.77 | 2020 | |
| Depuy Synthes Sales INC. | $14.04 | 2021 | |
| Integra Lifesciences Corporation | $12.87 | 2020 | |
| Smith+Nephew, INC. | $11.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Macdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.